2013 American Transplant Congress
Lipocalin-2 in Serum Samples of Recipients Following Liver Transplantation as Predictive and Monitoring Marker for Acute Allograft Rejection
PURPOSE: Lipocalin-2 (Lcn-2) has been described as a marker and modulator of inflammation during ischemia/reperfusion injury (IRI) following solid organ transplantation. Aim of this study…2013 American Transplant Congress
Early Look at the OPTN Explant Pathology Form Data, An
Background: Candidates with exceptions for hepatocellular carcinoma (HCC) accounted for 29% of liver transplants during the first 6 months of 2012. OPTN policy requires submission…2013 American Transplant Congress
Correlation of Global Copy Number Changes with Micro RNA Expression Profiling Reveals MUC1 as a Marker for HCC Recurrence after Transplant
INTRODUCTION: Epigenetic changes are known to play a pivotal role in hepatocellular carcinogenesis, but the effects of these changes on cancer cell protein expression remain…2013 American Transplant Congress
Exogenous Hydrogen Sulphide Mitigates Long-Term Renal Dysfunction Associated with Warm Renal Ischemia-Reperfusion Injury
Background:The incidence of renal cell carcinoma (RCC) is concurrently rising with increased prevalence of end-stage renal disease (ESRD) world-wide. Treatment for RCC is limited and…2013 American Transplant Congress
Retransplantation with or without Graft Nephrectomy. A Single Centre Experience
Renal Transplantation, Royal London Hospital, London, United Kingdom
Introduction:This study aims to review the impact of nephrectomy of a failed primary allograft on the graft survival of renal retransplantation.Material/Method:This is a retrospective study…2013 American Transplant Congress
Super Regions Can Reduce Geographic Disparities in Liver Transplantation
Abdominal Transplantation, University of Arizona, Tucson
Context: The significant geographic disparities in liver transplantation have been a point of contention in the transplant community. In the attempt to establish greater equity,…2013 American Transplant Congress
RIP3 Mediated Necroptosis Regulates Cardiac Allograft Inflammation and Survival
Despite recent advances in immunosuppression, patients who have undergone allogeneic cardiac transplantation still suffer from poorly understood chronic graft loss. Previous studies have shown that…2013 American Transplant Congress
Promising Outcomes after Long-Term Therapy with Everolimus in Kidney Transplant Patients: Two-Years Results of the CERTIC Registry
Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, is licensed for the prevention of acute rejection in heart or kidney transplant recipients. Based on the…2013 American Transplant Congress
Everolimus Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients: 12-24 Month Data from North America
Purpose: In Study H2304, everolimus (EVR) facilitated early tacrolimus (TAC) minimization with comparable efficacy and better renal function vs standard TAC at 12 months (M)…2013 American Transplant Congress
Evolving Trends in Living Donor Uninephrectomy Techniques and Impact on Post-Transplant Outcomes: A Review of the US National Cohort
MedStar Georgetown Transplant Institute, Washington, DC
Background: In the US majority of living donor uninephrectomy procedures for kidney transplantation are currently done by laparoscopic techniques. We wanted to assess the variations…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 178
- Next Page »